131 related articles for article (PubMed ID: 30220124)
1. [Cut-off value of Ki-67 labeling index in the pathologic grading of follicular lymphoma].
Hou WH; Duan XK; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):696-699. PubMed ID: 30220124
[No Abstract] [Full Text] [Related]
2. Grading follicular lymphoma on fine needle aspiration specimens. Comparison with proliferative index by DNA image analysis and Ki-67 labeling index.
Sun W; Caraway NP; Zhang HZ; Khanna A; Payne LG; Katz RL
Acta Cytol; 2004; 48(2):119-26. PubMed ID: 15085740
[TBL] [Abstract][Full Text] [Related]
3. PET/CT Assessment of Follicular Lymphoma and High Grade B Cell Lymphoma - Good Correlation with Clinical and Histological Features at Diagnosis.
Novelli S; Briones J; Flotats A; Sierra J
Adv Clin Exp Med; 2015; 24(2):325-30. PubMed ID: 25931367
[TBL] [Abstract][Full Text] [Related]
4. The Utility of Phosphohistone H3 (PHH3) in Follicular Lymphoma Grading: A Comparative Study With Ki-67 and H&E Mitotic Count.
Khieu ML; Broadwater DR; Aden JK; Coviello JM; Lynch DT; Hall JM
Am J Clin Pathol; 2019 May; 151(6):542-550. PubMed ID: 30788495
[TBL] [Abstract][Full Text] [Related]
5. [Immunohistochemical patterns of follicular dendritic cell meshwork and Ki-67 in small B-cell lymphomas].
Shi YF; Li XH
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):222-6. PubMed ID: 23928527
[TBL] [Abstract][Full Text] [Related]
6. Mitotic Index Determined by Phosphohistone H3 Immunohistochemistry for Precise Grading in Follicular Lymphoma.
Bedekovics J; Irsai G; Hegyi K; Beke L; Krenács L; Gergely L; Méhes G
Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):579-585. PubMed ID: 27997502
[TBL] [Abstract][Full Text] [Related]
7. Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature.
Miao Y; Hu S; Lu X; Li S; Wang W; Medeiros LJ; Lin P
Hum Pathol; 2016 Dec; 58():72-77. PubMed ID: 27544800
[TBL] [Abstract][Full Text] [Related]
8. Correlation of mitotic indices, AgNor count, Ki-67 and Bcl-2 with grade and stage in papillary urothelial bladder cancer.
Goyal S; Singh UR; Sharma S; Kaur N
Urol J; 2014 Mar; 11(1):1238-47. PubMed ID: 24595931
[TBL] [Abstract][Full Text] [Related]
9. Grading of follicular lymphoma: comparison of routine histology with immunohistochemistry.
Martinez AE; Lin L; Dunphy CH
Arch Pathol Lab Med; 2007 Jul; 131(7):1084-8. PubMed ID: 17616995
[TBL] [Abstract][Full Text] [Related]
10. Grading of follicular lymphoma in cytological samples.
Klopčič U; Lavrenčak J; Gašljević G; Bračko M; Pohar-Marinšek Ž; Kloboves-Prevodnik V
Cytopathology; 2016 Dec; 27(6):390-397. PubMed ID: 26869534
[TBL] [Abstract][Full Text] [Related]
11. Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features.
Wang SA; Wang L; Hochberg EP; Muzikansky A; Harris NL; Hasserjian RP
Am J Surg Pathol; 2005 Nov; 29(11):1490-6. PubMed ID: 16224216
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of histologic grade and Ki-67 proliferation index in follicular lymphoma.
Xue T; Yu BH; Yan WH; Jiang XN; Tian T; Zhou XY; Li XQ
Hematol Oncol; 2020 Dec; 38(5):665-672. PubMed ID: 32627854
[TBL] [Abstract][Full Text] [Related]
13. Divergent immunohistochemical expression of CD21 and CD23 by follicular dendritic cells with increasing grade of follicular lymphoma.
Kurshumliu F; Sadiku-Zehri F; Qerimi A; Vela Z; Jashari F; Bytyci S; Rashiti V; Sadiku S
World J Surg Oncol; 2019 Jul; 17(1):115. PubMed ID: 31269981
[TBL] [Abstract][Full Text] [Related]
14. Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy.
Ács B; Zámbó V; Vízkeleti L; Szász AM; Madaras L; Szentmártoni G; Tőkés T; Molnár BÁ; Molnár IA; Vári-Kakas S; Kulka J; Tőkés AM
Diagn Pathol; 2017 Feb; 12(1):20. PubMed ID: 28222768
[TBL] [Abstract][Full Text] [Related]
15. Software-automated counting of Ki-67 proliferation index correlates with pathologic grade and disease progression of follicular lymphomas.
Samols MA; Smith NE; Gerber JM; Vuica-Ross M; Gocke CD; Burns KH; Borowitz MJ; Cornish TC; Duffield AS
Am J Clin Pathol; 2013 Oct; 140(4):579-87. PubMed ID: 24045557
[TBL] [Abstract][Full Text] [Related]
16. Role of Ki-67 labeling index as an adjunct to the histopathological diagnosis and grading of astrocytomas.
Thotakura M; Tirumalasetti N; Krishna R
J Cancer Res Ther; 2014; 10(3):641-5. PubMed ID: 25313753
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas.
Devaprasath A; Chacko G
Neurol India; 2003 Sep; 51(3):336-40. PubMed ID: 14652433
[TBL] [Abstract][Full Text] [Related]
18. How reliable is the Ki-67 cytological index in grading pancreatic neuroendocrine tumors? A meta-analysis.
Li J; Lin JP; Shi LH; Wang WJ; Li AQ; Si JM; Chen SJ
J Dig Dis; 2016 Feb; 17(2):95-103. PubMed ID: 26713749
[TBL] [Abstract][Full Text] [Related]
19. Can the Ki-67 Labeling Index in Biopsy Specimens Predict the World Health Organization Grade of Rectal Neuroendocrine Tumors?
Sugimoto S; Hotta K; Shimoda T; Imai K; Ito S; Yamaguchi Y; Takizawa K; Kakushima N; Tanaka M; Kawata N; Yoshida M; Ishiwatari H; Matsubayashi H; Ono H
Dig Dis; 2018; 36(2):118-122. PubMed ID: 29130971
[TBL] [Abstract][Full Text] [Related]
20. Microvessel density and Ki-67 labeling index in esthesioneuroblastoma: is there a prognostic role?
Singh L; Ranjan R; Madan R; Arava SK; Deepak RK; Singh MK
Ann Diagn Pathol; 2015 Dec; 19(6):391-6. PubMed ID: 26343569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
